Intrasaccular Embolization Systems Market

Intrasaccular Embolization Systems Market Overview

Global intrassacular embolization systems market demand is anticipated to be valued at US$ 2,920.44 Million in 2022, forecast to grow at a CAGR of 7.2% to be valued at US$ 5,861.41 Million from 2022 to 2032. The demand is expected to soar up in East Asia owing to the recent surge in healthcare standards in emerging countries like Japan and China.

Report Attribute	Details
Estimated Base Year Value (2021)	US$ 2,715 Million
Expected Market Value (2022)	US$ 2,920.44 Million
Anticipated Forecast Value (2032)	US$ 5,861.41 Million
Projected Growth Rate (2022 to 2032)	7.2% CAGR

An aneurysm occurs when a section of an artery wall weakens, allowing it to balloon out or widen abnormally. A stroke, blood clots, and increased intracranial pressure can all result from a bleed. Intrasaccular Embolization Systems typically involve restricting blood flow in an aneurysm that has formed.

Intrassacular Embolization Systems are surgical interventions that are used to fill aneurysms. Typically, an embolic coil is inserted into the aneurysms and blood platelets in the brain are restricted. The Intrasaccular Embolization Systems promote rapid clotting and the prevention of further brain damage. The use of preventive stenting by Intrasaccular Embolization Systems reduces the risk of surgical intervention in adjacent parts of the brain.

Furthermore, endovascular repair is used to achieve hemostasis. The time required to receive the Intrasaccular Embolization procedure is critical to the survival of patients with intracranial aneurysms. The Intrasaccular Embolization System provides a significant advantage in terms of patient recovery.

Which are Some Prominent Drivers Spearheading Intrasaccular Embolization Systems Market Growth?

The rising incidence of brain aneurysms is a major driving factor for the Intrasaccular Embolization Systems market, owing to the rising burden of chronic diseases. Aneurysms account for approximately 10-12% of stroke cases, according to the American Brain Aneurysm Foundation. Whereas approximately 10% to 14% of people suffer from intracranial bleeding, which results in death.

The market for Intrasaccular Embolization Systems is being driven by an increase in new cases of venous diseases. Furthermore, the increased use of antihypertensive drugs raises the risk of intracranial aneurysms, increasing the demand for Intrasaccular Embolization Systems. The main advantage of a device-based Intrasaccular Embolization System is its quick action and reduced recovery time, which in the case of intracranial aneurysms results in the patient's well-being. The shorter onset of action of a coil or WEB system is expected to boost the market for Intrasaccular Embolization Systems.

The increasing prescription rate of antihypertensive drugs by physicians and the high clinical effectiveness of Intrasaccular Embolization Systems are expected to expand the market for Intrasaccular Embolization System. The increased use of venous dilators, combined with an increase in the number of patients with high blood pressure, is expected to increase the risk of aneurysms and stroke, propelling the market for Intrasaccular Embolization Systems.

What are the Challenges Faced by the Intrasaccular Embolization Systems Market Industry?

Rigid regulatory guidelines for devices used in Intrasaccular Embolization Systems, combined with the high cost of the procedure, are expected to limit the global Intrasaccular Embolization Systems Market's growth.

Why is North America emerging as an Opportunistic Intrasaccular Embolization Systems Market?

Because of higher technological advancement and recent FDA approvals for WEB systems, North America is expected to be the dominant market in the global intrasaccular embolization systems market during the forecast period.

How is Europe Contributing to Growth of the Intrasaccular Embolization Systems Market?

According to Future Market Insights, Europe is expected to provide immense growth opportunities for Intrasaccular Embolization Systems Market. Extensive applications in the health industry are keeping sales of Intrasaccular Embolization Systems Market afloat across the region.

Europe is generating high demand for Intrasaccular Embolization Systems Market, as these regions are witnessing an uptick in construction activity. Moreover, the chemical industry in these countries is also experiencing a major upsurge, which will generate favorable conditions for market growth.

Market Competition

The global market for Intrasaccular Embolization Systems is fragmented with large number of market players. Examples of some of the primary key players operating in the global Intrasaccular Embolization Systems market are MicroVention, Inc., Medtronic Plc., Stryker Corporation, Cook Medical, dePuySynthes, Kaneka Pharmaceuticals, Penubbra and Braile Biomedica among others.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 5.2% from 2022 to 2032
Base Year for Estimation	2021
Historical Data	2015 to 2020
Forecast Period	2022 to 2032
Quantitative Units	Revenue in USD Billion, Volume in Kilotons and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered	Product Type End User Region
Regions Covered	North America Latin America Europe East Asia South Asia Oceania Middle East & Africa
Key Countries Profiled	USA Canada Brazil Argentina Chile Peru Germany UK France Spain Italy Nordics BENELUX Australia & New Zealand China India ASEAN GCC South Africa Turkey Iran Israel
Key Companies Profiled	MicroVention, Inc. Medtronic Plc. Stryker Corporation Cook Medical dePuySynthes Kaneka Pharmaceuticals Penubbra Braile Biomedica
Customization	Available Upon Request

Key Segments Profiled in the Intrasaccular Embolization Systems Market Industry Survey

Product Type:

• Intrasaccular Embolic Coils
• Intrasaccular Woven Endobridge (WEB)
• Medina Intrasaccular Embolization Device
• Other Intrasaccular Embolization Product Types

End User:

• Intrasaccular Embolization for Hospitals
• Intrasaccular Embolization for Specialty Clinics
• Intrasaccular Embolization for Ambulatory Surgery Centres
• Intrasaccular Embolization for Other End Users

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa

Frequently Asked Questions

What is the anticipated growth of the intrasaccular embolization systems market until 2032?

FMI projects the global Intrasaccular Embolization Systems Market to expand at a 7.2% value CAGR by 2032

Which region is forecast to be the most lucrative for intrasaccular embolization systems market growth?

North America is expected to be the most opportunistic Intrasaccular Embolization Systems Market.

Which are some prominent Intrasaccular Embolization Systems Market manufacturers?

MicroVention, Inc., Medtronic Plc. and stryker are some prominent Intrasaccular Embolization Systems Market manufacturers